Common Management of Primary Rectal Carcinoma in Patients with Stage IV Disease at the Diagnosis

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 4999-5004

  Pasetto, Lara Maria ^a   Rossi, Elena ^a   Paris, Myriam Katya ^a   Lonardi, Sara ^a   Monfardini, Silvio ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Chemotherapy; Rectal cancer; Review; Stage IV

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RECTUM CARCINOMA; RECTUM SURGERY; REVIEW; SYMPTOM;

CLINICAL TRIALS; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; RECTAL NEOPLASMS;

EID: 0842278698     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics 1999. CA Cancer J Clin 49: 8-31, 1999.
2. AJCC American Joint Committee on Cancer. In: Fleming DI, Coper SJ, Henson ED, Hutter VR, Kennedy JB, Murphy PG, O'Sullivan B, Sobin HL, Yarbro WJ, eds. AJCC Cancer Staging Manual, 5th ed. Philadelphia-New York: Lippincott-Raven 83-90, 1997.
3. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444-1450, 1990.
4. Wood CB, Gillis CR and Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. J Clin Oncol 2: 285-288, 1976.
5. Lyass S, Zamir G, Matot I, Goitein D, Eid A and Jurim O: Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol 78(1): 17-21, 2001.
6. Lambert LA, Colacchio TA and Barth RJ Jr: Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 135(4): 473-479, 2000.
7. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 312: 1465-1472, 1985.
8. Fisher B, Wolmark N, Rockette H et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80: 21-29, 1988.
9. Krook JE, Moertel CG, Gunderson LL et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324: 709-715, 1991.
10. Gastrointestinal Tumor Study Group: Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Clin Oncol 10: 549-557, 1992.
11. Minsky BD, Conti JA, Huang Y and Knopf K: The relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13: 1409-1416, 1995.
12. Frykholm GJ, Glimelius B and Pahlman L: Preoperative and postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36: 564-572, 1993.
13. Kollmorgen CF, Meagher AP, Wolff BG et al: The long-term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function. Ann Surg 220: 676-682, 1994.
14. Paty PB, Enker WE, Cohen AM et al: Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 167: 90-95, 1994.
15. Chan AK, Wong AO, Langevin J et al: Sandwich preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: Impact of treatment intensity on local control and survival. Int J Radiat Oncol Biol Phis 37(3): 629-637, 1997.
16. Rich TA, Skibber JM, Ajani JA et al: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phis 32(4): 1025-1029, 1995.
17. Marsh RD, Chu NM, Vauthey JN et al: Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5FU infusion and radiation therapy. Cancer 78: 217-225, 1996.
18. Minsky BD, Cohen AM, Kemeny N et al: Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 10: 1218-1224, 1992.
19. Grann A, Minsky BD, Cohen AM et al: Preliminary results of preoperative 5FU, low-dose leucovorin and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 40: 515-522, 1997.
20. Chari RS, Tyler DS, Anscher MS et al: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221: 778-787, 1995.
21. Stryker SJ, Kiel KD, Rademaker A et al: Preoperative " chemoradiation" for stages II and III rectal carcinoma. Arch Surg 131: 514-519, 1996.
22. Pucciarelli S, Friso ML, Toppan P, Fornasiero A, Carnio S, Marchiori E and Lise M: Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results. Ann Surg Oncol 7(1): 38-44, 2000.
23. Enker WE, Merchant N, Cohen AM et al: Safety and efficacy of low anterior resection for rectal cancer. 681 consecutive cases from a specialty service. Ann Surg 230: 544-554, 1999.
24. Ooi BS, Tjandra JJ and Green MD: Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer. Dis Colon Rectum 42: 403-418, 1999.
25. Minsky BD: Multidisciplinary management of resectable rectal cancer. Oncology 10: 1701-1714, 1996.
26. Stockholm Rectal Cancer Study Group: Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 66: 49-55, 1990.
27. Cedermark B, Johansson H, Rutqvist LE and Wilking N: The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75: 2269-2275, 1995.
28. Stockholm Colorectal Cancer Study Group: Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 3: 423-430, 1996.
29. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336: 980-987, 1997.
30. Minsky BD: Adjuvant therapy of rectal cancer. Semin Oncol 26: 540-544, 1999.
31. Dahlberg M, Glimelius B, Graf W and Pahlman L: Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 41: 543-549, 1998.
32. Serpell PW, McDermott FT, Katrivessis H and Hughes ES: Obstructing carcinomas of the colon. Br J Surg 76: 965-969, 1989.
33. Griffin MR, Bergstrahl MS, Coffey RI et al: Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 60: 2318-2324, 1987.
34. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ and O'Riordain DS: Non-operative management of the primary tumor in patients with incurable stage IV colorectal cancer. Br J Surg 88(10): 1352-1356, 2001.
35. Donovan MP, Yeung ST, John TG and Rees M: Rectal adenocarcinoma with liver metastases: management of the primary tumor. Br J Surg 88: 163-164, 2001.
36. Julianov A and Stoyanov H: Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 88 (9): 1264, 2001.
37. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM and Wong WD: Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196(5):722-728, 2003.
38. Scoggins GR, Meszoely IM, Blanke CD, Beauchamp RD and Leach SD: Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6(7): 651-657, 1999.
39. Joffe J and Gordon PH: Palliative resection for colorectal carcinoma. Dis Colon Rectum 24: 355-360, 1981.
40. Liu SKM, Church JM, Lavery IC and Fazio VW: Operations in patients with incurable colon cancer - is it worthwhile? Dis Colon Rectum 40: 11-14, 1997.
41. Makela J, Haukipuro K, Laitinen S and Kairaluoma MI: Palliative operations for colorectal cancer. Dis Colon Rectum 33: 846-850, 1990.
42. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, Millis M and Posner MC: Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135: 530-534, 2000.
43. Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 230: 309-318, 1999.
44. Nordic Gastrointestinal Tumor Adjuvant Therapy Group: Expectancy of primary chemotherapy in patients with advanced symptomatic colorectal cancer: a randomized trial. J Clin Oncol 10: 904-911, 1992.
45. Scheithauer W, Rosen H, Kornek GV et al: Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 306: 752-755, 1993.
46. De Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E and Bedenne L: Randomized trial comparing monthly low dose leucovorin and 5FU bolus with bimonthly high-dose leucovorin and fluorouracil bolus continuous infusion for advanced colorectal cancer: a French Intergroup Study. J Clin Oncol 15(2): 808-815, 1997.
47. Comella P, De Vita F, De Lucia L, Lorusso V, Biglietto M, Ianniello G P, Leo S, Farris A, Del Gaizo F, Casaretti R, Orditura M, Mancarella S, Catalano G, Zeppetella G, Brunetti C, Buzzi F and Comella G: Biweekly treatment with either irinotecan or tomudex followed by levo leucovorin modulated 5FU bolus in advanced colorectal carcinoma. Proc Am Soc Clin Oncol 19: 257 (abs 998), 2000.
48. Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kupermic M, Maroun J, Walde D et al: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19(8): 2282-2292, 2001.
49. Rougier P, Van CE, Bajetta E et al: Randomized trial of irinotecan versus fluorouracil continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352: 1407-1412, 1998.
50. Cunnigham D, Pyrhonen S, James RD et al: Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352: 1413-1418, 1998.
51. Saltz LB, Cox JV, Blanke C et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914, 2000.
52. Douillard JY, Cunnigham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Award L and Rougier P: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial. Lancet 355(9209): 1041-1047, 2000.
53. Giacchetti S, Bjarnason GA, Garufi C, Canon N, Humblet Y, Tumolo S, Carvalho C, Adenis A et al: First line infusion of 5FU, leucovorin, oxaliplatin for metastatic colorectal cancer chronomodulated versus conventional delivery, a multicenter randomized trial of the EORTC chronotherapy group. Proc Am Soc Clin Oncol 21: 104 (abs 2231), 2002.
54. Leslie A and Steele RJC: Management of colorectal cancer. Postgraduated Med J 78: 473-478, 2002.
55. Chari RS, Tyler DS, Anscher MS et al: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221: 778-787, 1995.
56. Mynt AS: The role of radiotherapy in the palliative treatment of gastrointestinal cancer. Eur J Gastroenterol Hepatol 12(4): 381-390, 2000.
57. Seymour MT: Colorectal cancer: treatment of advanced disease. Cancer Treat Rev 24: 119-131, 1998.
58. Krook JE, Moertel CG, Gunderson LL et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324: 709-715, 1991.
59. Moran MR, Rothemberg DA, Lahr CI et al: Palliation for rectal cancer. Arch Surg 122: 610-613, 1987.
60. Longo WE, Ballanryne GH, Bilchik AJ and Modlin IM: Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 31: 842-847, 1988.
61. Daneker GW: Endoscopic laser recanalization is effective for option and treatments of obstruction in sigmoid and rectal cancer? Arch Surg 126: 1348-1352, 1991.
62. Sarela A and O'Riordain DS: Rectal adenocarcinoma with liver metastases: management of the primitive tumor. Br J Surg 88: 163-164, 2001.
63. Simmonds P: Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. Br Med J 321: 531-535, 2000.